MOTHAFFAR RIMAWI to Receptor, IGF Type 1
This is a "connection" page, showing publications MOTHAFFAR RIMAWI has written about Receptor, IGF Type 1.
Connection Strength
0.104
-
High IGF-IR activity in triple-negative breast cancer cell lines and tumorgrafts correlates with sensitivity to anti-IGF-IR therapy. Clin Cancer Res. 2011 Apr 15; 17(8):2314-27.
Score: 0.086
-
Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function. Cancer Res. 2008 Feb 01; 68(3):826-33.
Score: 0.018